Clinical Trials for Pancreatic Cancer

201410102

Positron emission tomography (PET) imaging of poly(ADP-ribose) polymerase (PARP) activity in cancer Phase Early Phase I Principal Investigator Dehdashti, Farrokh Disease Site Anus; Bones and Joints; Brain and Nervous System; Breast; Cervix; Colon; Corpus Uteri;…

201805016

A Phase II Multi-Center Study of SM-88 in Subjects with Pancreatic Cancer Whose Disease Has Progressed or Recurred after/on First Line Chemotherapy Phase II/III Principal Investigator Tan, Benjamin Disease Site Pancreas Learn more about this…

201806007

A phase I/II study to evaluate the tolerability and efficacy of BMS-813160 (CCR2/5 inhibitor) with nivolumab and gemcitabine and nab-paclitaxel in borderline resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC) Phase I/II Principal Investigator Lim,…

201807099

Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy Phase I Principal Investigator Dehdashti, Farrokh Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

201812139

Prospective phase II Study of Stereotactic MR-guided on-table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Inoperable Locally Advanced Pancreatic Cancer Phase II Principal Investigator Kim, Hyun Disease Site Pancreas Learn more about this…

201908124

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy Phase I Principal Investigator Gillanders, William Disease Site…

201911155

A Phase 1 Study to Evaluate the Safety and Tolerability of AB680 Combination Therapy in Participants with Gastrointestinal Malignancies Phase I (Cancer Control) Principal Investigator Lim, Kian-Huat Disease Site Pancreas Learn more about this study…

201911159

PRECISION PROMISE PLATFORM TRIAL FOR METASTATIC PANCREATIC CANCER Phase III (Cancer Control) Principal Investigator Lim, Kian-Huat Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202001128

A phase I/Ib, open-label, multi-center, study of KAZ954 as a single agent and in combination with Spartalizumab, NZV930 and NIR178 in patients with advanced solid tumors Phase Early Phase I (Cancer Control) Principal Investigator Park,…

202007090

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer Phase III Principal Investigator Hawkins, William Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202009002

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT) Phase II Principal Investigator Lim, Kian-Huat Disease Site Pancreas…

202011019

Targeting pancreatic cancer with sodium glucose transporter 2 (SGLT2) inhibition Phase I Principal Investigator Lim, Kian-Huat Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202011125

Testing the immunologic effects of CDX-301 and CDX-1140 in resectable pancreatic cancer patients Phase II Principal Investigator Hawkins, William Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202106061

Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma Phase II Principal Investigator Kim, Hyun Disease Site Pancreas Learn more about this study at: clinicaltrials.gov